Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Westerlind

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|November 17, 2022
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: replyHelga Westerlind, Alf Kastbom, Johan Askling
RMD Open|May 20, 2020
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort studyHelga Westerlind, Bénédicte Delcoigne, Johan Askling
RMD Open|March 16, 2026
Can alternative means of phenotyping rheumatoid arthritis reduce its apparent heterogeneity? A comparison of three disease activity classifications with DAS28Simon Steiger, Helga Westerlind, Daniela Di Giuseppe, et al.
Brain : a Journal of Neurology|April 23, 2014
Reply: Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studiesHelga Westerlind, Ralf Kuja-Halkola, Ryan Ramanujam, et al.
ACR Open Rheumatology|March 9, 2022
Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After DiagnosisJoakim Lindqvist, Lars Alfredsson, Lars Klareskog, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by EyubogluHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|November 17, 2022
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: replyHelga Westerlind, Alf Kastbom, Johan Askling
RMD Open|May 20, 2020
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort studyHelga Westerlind, Bénédicte Delcoigne, Johan Askling
RMD Open|March 16, 2026
Can alternative means of phenotyping rheumatoid arthritis reduce its apparent heterogeneity? A comparison of three disease activity classifications with DAS28Simon Steiger, Helga Westerlind, Daniela Di Giuseppe, et al.
Brain : a Journal of Neurology|April 23, 2014
Reply: Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studiesHelga Westerlind, Ralf Kuja-Halkola, Ryan Ramanujam, et al.
ACR Open Rheumatology|March 9, 2022
Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After DiagnosisJoakim Lindqvist, Lars Alfredsson, Lars Klareskog, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by EyubogluHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|December 17, 2020
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Pageof 7